ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Circulating DNA addresses cancer monitoring in non small cell lung cancer patients for detection and capturing the dynamic changes of the disease

Wei Z; Shah N; Deng C; Xiao X; Zhong T; Li X*华中科技大学; 1
SpringerPlus2016DOI: 10.1186/s40064-016-2141-5
24阅读
引用收藏
分享

摘要

Purpose: Monitoring of key markers for lung cancer detection and tracking of acquired drug resistance is critical for the management of the disease. We aim to ascertain the value of monitoring both total cell free DNA concentrations and mutant EGFR DNA content within diverse groups of individuals most vulnerable to the disease. Methods: We proposed longitudinal monitoring of circulating DNA using digital PCR. Circulating DNA present in peripheral blood can be obtained non-invasively and provide timely disease status update. 25 heavy smokers and 50 patients undergoing TKI therapy were recruited. Peripheral blood specimens were taken at different time points and their circulating DNA were analyzed and quantified. Results: Significant higher concentrations of total cell free DNA were detected when compared with healthy high-risk individuals. Levels were stable throughout the treatment cycles, which makes it potentially a useful tool for patient stratification. Concurrent mutant T790M DNA detection of lung cancer patients at baseline achieved 82  concordance with matched tissue analysis. Samples initially negative for the T790M gene mutation that became positive during treatment were corroborated with a repeat biopsy. The results showed its usefulness for serial monitoring. Conclusion: Monitoring of circulating DNA addresses the need for disease detection and shows the ability to capture the dynamic changes of the disease.

学科与关键词

关键词
cfDNActDNADrug resistanceNon small cell lung cancer (NSCLC)T790M mutation
相关
加载中…
  • EGFR mutation analysis on circulating free DNA in NSCLC: a single-center experience
    Ianza, Anna*; Di Chicco, A.; Biagi, C.; Giudici, F.; Dicorato, A.; Guglielmi, A.; Variola, F.; Tomasi, S.; Roviello, G.; Generali, D.; Zanconati, F.Journal of Cancer Research and Clinical Oncology.
  • Circulating tumor DNA analysis of EGFR -mutant non-small cell lung cancer patients receiving osimertinib following previous tyrosine kinase inhibitor treatment
    Jamie J. Beagan; Sander Bach; Robert A. van Boerdonk; Erik van Dijk; Erik Thunnissen; Daan van den Broek; Janneke Weiss; Geert Kazemier; D Michiel Pegtel; Idris Bahce; Bauke Ylstra; Daniëlle A.M. HeidemanLung Cancer, 2020, 145: 173-180.被引 6
  • DYNAMIC, QUANTITATIVE, AND NON-INVASIVE ANALYSIS OFT790M MUTATION IN MATCHED PLASMA DNA FROM PRE-AND POST-EGFR-TKI TREATMENT FOR ADVANCED NON-SMALL CELL LUNG CANCER
    Chen Rui; Bai Hua; Wang Shuhang; Wang Yuyan; Duan Jianchun; Wang Jie; An Tongtong; Zhuo Minglei; Wu Meina
查看全部 →

发表信息

论文状态
公开发表
期刊
SpringerPlus
发表日期
2016
卷期
第 5 卷, 第 1 期
DOI
10.1186/s40064-016-2141-5
成果收录
SCOPUS

作者

  • W

    Wei Z (第一作者)

    1

  • S

    Shah N

查看全部 6 位作者收起作者
  • D

    Deng C

    1

  • X

    Xiao X

    1

  • Z

    Zhong T

    1

  • L

    Li X (通讯)

    1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417